Milestone Scientific

Global Expansion And Minimally Invasive Care Will Shape Future Progress

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

07 Apr 25

Updated

04 Dec 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-53.8%

7D

12.1%

Loading

1Y

-53.8%

7D

12.1%

You can edit this narrative until Dec 5 5:05 PM. Then, changes will post as Updates.

Author's Valuation

US$161.0% undervalued

AnalystConsensusTarget Fair Value

Shared on 04 Dec 25

Fair value Decreased 11%

MLSS: Shares Will Likely Rebound As NYSE Compliance Plan Progresses

Analysts have trimmed their price target on Milestone Scientific from 1.13 dollars to 1.00 dollars, citing slightly slower expected revenue growth and a modestly lower valuation multiple. This is partially offset by stable profit margin assumptions and a marginally reduced discount rate.

Shared on 20 Nov 25

Fair value Decreased 31%

MLSS: Shares Will Face Key NYSE American Compliance Decision by 2027

Analysts have revised their price target for Milestone Scientific downward from $1.63 to $1.13. They cite lower projected revenue growth and a higher discount rate as key factors influencing their updated outlook.

Shared on 19 Aug 25

Fair value Decreased 24%

The downward revision in Milestone Scientific’s price target reflects materially lower revenue growth expectations, leading to a drop in projected fair value from $2.12 to $1.62. What's in the News Eric C.

Shared on 01 May 25

Fair value Increased 1.67%

Shared on 24 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

Fair value Increased 5.03%

AnalystConsensusTarget has increased revenue growth from 18.6% to 22.6%.

Shared on 09 Apr 25

Fair value Decreased 6.35%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

AnalystConsensusTarget Fair Value

US$1

61.0% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

7.12%

Medical Equipment revenue growth rate

8.17%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

7.74%

Calculation

US$1.48m

Earnings '28

x

66.80x

PE Ratio '28

=

US$98.94m

Market Cap '28

US$98.94m

Market Cap '28

/

79.38m

No. shares '28

=

US$1.25

Share Price '28

US$1.25 Share Price '28

Discounted to 2025 @ 7.79% p.a.

=

US$1.00

Fair Value '25